4//SEC Filing
Dybbs Michael 4
Accession 0001209191-22-035208
CIK 0001382101other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:05 PM ET
Size
5.6 KB
Accession
0001209191-22-035208
Insider Transaction Report
Form 4
Dybbs Michael
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-06+18,500→ 18,500 totalExercise: $4.44Exp: 2032-06-05→ Common Stock (18,500 underlying)
Footnotes (1)
- [F1]The option vests as to 8.33% of the total shares monthly, commencing July 6, 2022, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2023 annual stockholders meeting or June 6, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001601264
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 7:05 PM ET
- Size
- 5.6 KB